Showing results (281-290 of 297) with videos related to
Sort By:
Pageof 30
FEBS Letters|September 19, 2024
The splicing factor hnRNPL demonstrates conserved myocardial regulation across species and is altered in heart failureIsabelle Draper, Wanting Huang, Suchita Pande, et al.Science Translational Medicine|April 29, 2021
SynNotch-CAR T cells overcome challenges of specificity, heterogeneity, and persistence in treating glioblastomaJoseph H Choe, Payal B Watchmaker, Milos S Simic, et al.Ophthalmology|June 8, 2014
Bilateral lacrimal gland disease: clinical features of 97 casesSunny X Tang, Renelle P Lim, Saad Al-Dahmash, et al.Nature Communications|May 27, 2017
The distinct metabolic phenotype of lung squamous cell carcinoma defines selective vulnerability to glycolytic inhibitionJustin Goodwin, Michael L Neugent, Shin Yup Lee, et al.Journal of the National Cancer Institute|December 4, 2025
Cisplatin during radiation for head and neck cancer: insights from NRG Oncology experienceLuana G Sousa, James Edward Bates, Payal Anand, et al.Biorxiv : the Preprint Server for Biology|September 26, 2025
VEGFR2 blockade overcomes acquired KRAS G12D inhibitor resistance driven by PI3Kγ activationSung-Hyun Hwang, Mingyun Bae, Ji-Won Kim, et al.The Lancet. Oncology|October 24, 2023
Neoadjuvant cemiplimab and surgery for stage II-IV cutaneous squamous-cell carcinoma: follow-up and survival outcomes of a single-arm, multicentre, phase 2 studyNeil D Gross, David M Miller, Nikhil I Khushalani, et al.Biorxiv : the Preprint Server for Biology|November 22, 2024
Tenascin-C potentiates Wnt signaling in thyroid cancerHeather A Hartmann, Matthew A Loberg, George J Xu, et al.The New England Journal of Medicine|September 12, 2022
Neoadjuvant Cemiplimab for Stage II to IV Cutaneous Squamous-Cell CarcinomaNeil D Gross, David M Miller, Nikhil I Khushalani, et al.Endocrinology|February 14, 2025
Tenascin-C Potentiates Wnt Signaling in Thyroid CancerHeather A Hartmann, Matthew A Loberg, George J Xu, et al.Pageof 30